⌘K

Login Start Free

Home/Filings/4/0001999371-24-002952

4//SEC Filing

LEDERMAN SETH 4

Accession 0001999371-24-002952

CIK 0001430306other

View on SEC.gov Company Profile

Filed

Feb 28, 7:00 PM ET

Accepted

Feb 29, 5:08 PM ET

Size

10.1 KB

Accession

0001999371-24-002952

Insider Transaction Report

Form 4

Period: 2024-02-27

Tonix Pharmaceuticals Holding Corp.TNXP

DirectorPresident and CEO

Transactions

Award
Stock Option
2024-02-27+235,320→ 235,320 total
Exercise: $0.37From: 2025-02-27Exp: 2034-02-27→ Common Stock (235,320 underlying)
Award
Stock Option
2024-02-27+1,903,680→ 1,903,680 total
Exercise: $0.46From: 2025-02-27Exp: 2034-02-27→ Common Stock (1,903,680 underlying)
Award
Stock Option
2024-02-27+1,309,911→ 1,309,911 total
Exercise: $0.04From: 2024-08-27Exp: 2034-02-27→ Common Stock (1,309,911 underlying)

Footnotes (2)

[F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
[F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

Documents

1 file

4
lederman-form4_022724.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1

filerCIK 0001563420

Filing Metadata

Form type: 4
Filed: Feb 28, 7:00 PM ET
Accepted: Feb 29, 5:08 PM ET
Size: 10.1 KB

View on SEC.gov